Xebio Holdings Co., Ltd. (8281.T)

JPY 1143.0

(0.26%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 242.43 Billion 239.29 Billion 223.28 Billion 202.43 Billion 225.31 Billion 231.62 Billion
Cost of Revenue 153.93 Billion 147.51 Billion 136.22 Billion 123.61 Billion 136.58 Billion 143.73 Billion
Gross Profit 88.49 Billion 91.77 Billion 87.05 Billion 78.82 Billion 88.72 Billion 87.89 Billion
Operating Expenses 88.68 Billion 83.44 Billion 82.05 Billion 76.05 Billion 83.47 Billion 82.13 Billion
Selling, General and Administrative Expenses 84.29 Billion 80 Billion 78.58 Billion 72.54 Billion 80.08 Billion 78.5 Billion
Research and Development Expenses - - - - - -
Other Expenses 4.39 Billion 709 Million 2.35 Billion 1.49 Billion 605 Million 870 Million
Cost and Expenses 238.22 Billion 230.96 Billion 218.28 Billion 199.67 Billion 220.06 Billion 225.86 Billion
Operating Income 4.2 Billion 8.32 Billion 4.99 Billion 2.76 Billion 5.24 Billion 5.76 Billion
Interest Expense 104 Million 64 Million 120 Million 124 Million 26 Million 12 Million
Income Tax Expense 1.78 Billion 3.24 Billion 2.36 Billion 2.68 Billion 2.76 Billion 2.45 Billion
Earnings before Tax 4.52 Billion 8.83 Billion 6.21 Billion 3.09 Billion 3.18 Billion 4.35 Billion
Net Income 2.59 Billion 5.39 Billion 3.83 Billion 412 Million 408 Million 1.88 Billion
Earnings Per Share Basic 58.63 122.07 86.77 9.32 9.23 42.40
Earnings Per Share Diluted 58.32 121.57 86.44 9.29 9.20 42.32
Weighted Average Shares Outstanding 44.21 Million 44.21 Million 44.21 Million 44.21 Million 44.21 Million 44.43 Million
Weighted Average Shares Outstanding (Diluted) 44.44 Million 44.39 Million 44.37 Million 44.34 Million 44.32 Million 44.51 Million
Gross Margin 0.37 0.38 0.39 0.39 0.39 0.38
EBIT Margin 0.04 0.06 0.05 0.04 0.05 0.05
Profit Margin 0.01 0.02 0.02 0.00 0.00 0.01
EBITDA 9.29 Billion 12.39 Billion 9.24 Billion 7.22 Billion 9.68 Billion 10.27 Billion
Earnings Before Tax Margin 0.02 0.03 0.02 0.01 0.02 0.02

Income Statement Charts